Search

everythinglearnresearchcommunity

for

Search:↓

A man's hair grew back to almost normal 7 months after COVID-19 without needing treatment.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Men with hair loss are more likely to experience moderate to severe COVID-19 symptoms.

Hair loss link to COVID-19 severity likely due to other factors.

Large prostates link to more hair loss.

Azelaic acid's effectiveness in treating certain skin conditions needs more research.

Oral cyclosporin doesn't stop hair loss.

A multimodal approach successfully restored a burn victim's scalp hair over 10 years.

Combining platelet-rich plasma with other treatments may improve hair growth in people with hair loss, but more research is needed.

Different types of hair loss are linked to COVID-19, with some types possibly increasing risk of getting the virus, while others may be triggered or worsened by the virus.

Horizontal sections of scalp biopsies are useful for telling the difference between Androgenetic Alopecia and Alopecia Areata.

Phototherapy can improve various types of hair loss with minimal side effects, but more research is needed to optimize treatment.

Melanoma patients can learn to check their skin, early balding in men may indicate similar risks as PCOS in women, certain criteria can help predict skin cancer behavior, small skin cancer may not need extra therapy after surgery, and sterile gloves don't reduce infection in minor surgeries.

Dense-packing hair grafting is a simple, safe, and effective way to restore hair in people with cicatricial alopecia.

Microneedling with platelet-rich plasma can cause temporary, painful lymph node swelling in some patients.

Most hair loss in captive rhesus macaques is likely due to environmental and behavioral factors.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Certain fungi may contribute to hair loss in cynomolgus macaques.

Baricitinib is effective for severe alopecia areata but has some side effects.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Accurate diagnosis and tailored treatments are crucial for managing hair loss in humans and animals.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.